NITRIC OXIDE SIGNALING IN ALLERGIC AIRWAY DISEASE
NITRIC OXIDE SIGNALING IN ALLERGIC AIRWAY DISEASE
批准号:
6948828
负责人:
ALBERT VAN DER VLIET
金额:
$38.0万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2008-08-31
关键词:
active immunizationasthmabiological signal transductiondisease /disorder modelenzyme activitygene expressiongenetically modified animalsimmunochemistryimmunoprecipitationinflammationlaboratory mouselaser capture microdissectionlungmatrix assisted laser desorption ionizationmetabolismnitrationnitric oxidenitric oxide synthasenitroso compoundsnuclear factor kappa betaovalbuminoxidationrespiratory epitheliumrespiratory functiontissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asthma is characterized by airway hyperreactivity and remodeling, and chronic inflammation of the conducting airways. A critical event in the inflammatory response with the airways is the epithelial activation of nuclear factor ?B (NF-?B), a transcription factor that regulates the expression of many genes involved in the inflammatory process. Induction of nitric oxide (NO) synthase is a common feature of airway inflammation, and various cell studies have illustrated inhibitory effects of NO" on NF ?B mediated gene expression, presumably by S-nitrosation of critical proteins. Since inflammatory conditions involve recruitment of granulocytes and activation of oxidant-producing enzymes, such as eosinophil peroxidase (EPO), metabolism of NO" is likely to be altered because of oxidative conversion to potentially proinflammatory reactive nitrogen species (RNS), and bioactivity of NO" (through S-nitrosation) may be reduced. Indeed, subnormal S-nitrosothiol levels have been found in airway secretions of severe asthmatics, and formation of RNS has been demonstrated by increased tyrosine nitration. We therefore hypothesize that increased oxidative NO" metabolism results in reduced S-nitrosation of components of the NF-?B pathway, thereby promoting its chronic activation and consequently augmenting airway inflammation. Addressing such a hypothesis has been difficult because of a lack of adequate tools to detect S-nitrosoproteins in intact cells or tissues. We have adapted a recently developed procedure, based on chemical derivatization to selectively biotinylate and/or purify S-nitrosated proteins, allowing us to detect S-nitrosated proteins in intact tissue sections and to collect S-nitrosated proteins for identification of cellular targets by more global proteomic analysis. We plan to use these approaches to determine changes in S-nitrosation in relation to NO metabolism in a mouse model of allergic airway inflammation (Aim 1), and to identify changes in S-nitrosation in specific proteins in relation to alterations in NF-?B activation and gene expression, in cultured airway epithelial cells (Aim 2) and in airway of mice with allergic airway inflammation (Aim 3). Finally, with the use of various (knock-out) models of deficiency in EPO or myeloperoxidase (MPO) and of overexpression of catalase, we plan to explore a role of oxidant-producing enzymes in alterations in NO" metabolism, and in changes in S-nitrosation of proteins involved in NF-?B activation and gene expression. Collectively, we anticipate that these studies will provide causal links between NO" metabolism, NF-?B activation, and chronic airway inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DUOX1 in fibroblast-macrophage cross-talk in pulmonary fibrosis
-
批准号:10544804
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2022
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
DUOX1 in fibroblast-macrophage cross-talk in pulmonary fibrosis
-
批准号:10353646
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2022
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
NOX Family NADPH Oxidases GRC/GRS
-
批准号:10463998
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
DUOX1 and Mitochondria in Obese Asthma
-
批准号:9386934
-
项目类别:
-
资助金额:$53.24万
-
财政年份:2017
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
DUOX1 Silencing in Age-Related COPD
-
批准号:9262578
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2017
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
-
批准号:8484841
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
-
批准号:8815177
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
-
批准号:8628126
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
-
批准号:8272910
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Repair and Remodeling
-
批准号:7808841
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Repair and Remodeling
-
批准号:7533224
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Injury and Inflammation
-
批准号:8704447
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Injury and Inflammation
-
批准号:8850477
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Injury and Inflammation
-
批准号:9397831
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Repair and Remodeling
-
批准号:7667757
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Injury and Inflammation
-
批准号:8598274
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
Dual Oxidase in Airway Epithelial Injury and Inflammation
-
批准号:9982119
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2008
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
NITRIC OXIDE SIGNALING IN ALLERGIC AIRWAY DISEASE
-
批准号:6776107
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2004
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
NITRIC OXIDE SIGNALING IN ALLERGIC AIRWAY DISEASE
-
批准号:7109303
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2004
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
NITRIC OXIDE SIGNALING IN ALLERGIC AIRWAY DISEASE
-
批准号:7275975
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2004
-
负责人:ALBERT VAN DER VLIET
-
依托单位:
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
-
批准号:30873315
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:周兆山
-
依托单位:
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
-
批准号:30740048
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2007
-
负责人:李海潮
-
依托单位:
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
-
批准号:30672268
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2006
-
负责人:符州
-
依托单位: